World's First Genome Editing Platform That Can Be Fine Tuned
Patented Safeguard genome editing technology that enables fine tuning of genome editing to optimize precision, efficacy and safety
A revolutionary technology that enhances the safety and precision of CRISPR gene editing, enabling the development of transformative therapies for genetic diseases, cancer, and longevity.
7x HDR Efficiency
Continuous fine-tuning is important for determining the optimal range of Cas activity which maximizes HDR efficiency
Prioritizes safety by significantly reducing adverse effects such as p53 activation, cytotoxicity and DNA damage, ensuring that gene editing is performed accurately and securely.
Unparalleled precision, lowering off-targets, enabling genome editing with increased accuracy and control
Partnerships and Collaborations
Harvard Medical School
We Take Pride in Our Numbers